Related Experiment Video
Updated: Jul 9, 2026

10:41
Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
High-throughput mutational screening for beta-thalassemia by single-nucleotide extension
Silvia Galbiati1, Marcella Chiari, Micol Macellari
1Genomic Unit for the Diagnosis of Human Pathologies, San Raffaele Scientific Institute, Milano, Italy.
Electrophoresis
|November 28, 2007
Summary
A new high-throughput method using single-nucleotide extension (SNE) and multicolour detection screens for eight beta-globin gene mutations. This fast, reliable assay improves molecular diagnosis of beta-thalassemia, aiding automated genotyping.
Area of Science:
- Molecular Biology
- Genetics
- Medical Diagnostics
Background:
- Beta-thalassemia is a significant genetic blood disorder.
- Accurate and efficient molecular diagnosis is crucial for managing beta-thalassemia.
- Existing diagnostic methods may lack high-throughput capabilities.
Purpose of the Study:
- To develop a high-throughput method for screening beta-globin gene mutations.
- To validate the method for common beta-thalassemia mutations in the Mediterranean region.
- To enhance molecular diagnostics for beta-thalassemia.
Main Methods:
- Development of a single-nucleotide extension (SNE) reaction.
- Utilizing multicolour detection in a DNA sequencer.
- Screening for eight specific human beta-globin gene mutations, including IVSI.110 and cd39.
Main Results:
- Successfully developed and validated a high-throughput SNE method.
- Demonstrated reliability for common Mediterranean beta-thalassemia mutations (IVSI.110, cd39).
- The method facilitates automated genotyping for routine diagnostics.
Conclusions:
- The developed SNE method offers a significant advancement in beta-thalassemia molecular diagnosis.
- Multicolour detection and multiple injections increase throughput for mutational screening.
- This facilitates faster and more efficient automated genotyping for clinical settings.

